These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 722302)

  • 41. [Body dysmorphic disorder and psychosis. Case reports and discussion].
    Loréa N; Van Wijnendaele R
    Encephale; 2012 Feb; 38(1):37-41. PubMed ID: 22381722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Body image disturbance in body dysmorphic disorder and eating disorders. Obsessions or delusions?
    Phillips KA; Kim JM; Hudson JI
    Psychiatr Clin North Am; 1995 Jun; 18(2):317-34. PubMed ID: 7659601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of previously intractable depressions with tranylcypromine and lithium.
    Himmelhoch JM; Detre T; Kupfer DJ; Swartzburg M; Byck R
    J Nerv Ment Dis; 1972 Sep; 155(3):216-20. PubMed ID: 5053920
    [No Abstract]   [Full Text] [Related]  

  • 44. Delusional and nondelusional unipolar depression: further evidence for distinct subtypes.
    Charney DS; Nelson JC
    Am J Psychiatry; 1981 Mar; 138(3):328-33. PubMed ID: 6110345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical aspects of therapy-resistant depression.
    Leonard BE
    Br J Psychiatry; 1988 Apr; 152():453-9. PubMed ID: 3048524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treating delusional depressives with amitriptyline.
    Spiker DG; Dealy RS; Hanin I; Weiss JC; Kupfer DJ
    J Clin Psychiatry; 1986 May; 47(5):243-6. PubMed ID: 3516978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression.
    Thase ME; Mallinger AG; McKnight D; Himmelhoch JM
    Am J Psychiatry; 1992 Feb; 149(2):195-8. PubMed ID: 1734739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
    Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I
    Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delusional depression: phenomenology and response to treatment.
    Lykouras E; Malliaras D; Christodoulou GN; Moussas G; Christodoulou D; Tzonou A
    Psychopathology; 1986; 19(4):157-64. PubMed ID: 2882542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapy of affective disorders with tianeptine in patients with essential hypertension].
    Rumiantseva GM; Sokolova TN; Levina TM; Margolina VIa
    Kardiologiia; 2003; 43(3):28-32. PubMed ID: 12891255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age as a predictor of treatment response in endogenous depression.
    Brown RP; Sweeney J; Frances A; Kocsis JH; Loutsch E
    J Clin Psychopharmacol; 1983 Jun; 3(3):176-8. PubMed ID: 6875025
    [No Abstract]   [Full Text] [Related]  

  • 53. Monoamine oxidase inhibitors. A review of antidepressant effectiveness.
    Quitkin F; Rifkin A; Klein DF
    Arch Gen Psychiatry; 1979 Jul; 36(7):749-60. PubMed ID: 454092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic effect of tranylcypromine in endogenous depressions. Comparison with other antidepressive drugs].
    Náhunek K; Svestka J
    Cesk Psychiatr; 1972 Feb; 68(1):3-11. PubMed ID: 5010897
    [No Abstract]   [Full Text] [Related]  

  • 55. The treatment of psychotic depression.
    Coryell W
    J Clin Psychiatry; 1998; 59 Suppl 1():22-7; discussion 28-9. PubMed ID: 9448666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative study of the electrocardiographic effects of tranylcypromine and amitriptyline when prescribed singly and in combination.
    O'Brien S; McKeon P; O'Regan M
    Int Clin Psychopharmacol; 1991; 6(1):11-7. PubMed ID: 2071885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comments on article by Dr Birkenhager et al: "Efficacy of imipramine in psychotic versus nonpsychotic depression".
    Baldessarini RJ
    J Clin Psychopharmacol; 2008 Dec; 28(6):716; author reply 717-8. PubMed ID: 19011451
    [No Abstract]   [Full Text] [Related]  

  • 58. [The comparative studies of therapeutic results in patients with psychotic refractory depression treated with selected antidepressants and unilateral ECT].
    Hese RT; Gruszczyński W; Szwed A; Kielc M; Zalitacz M
    Psychiatr Pol; 2002; 36(6 Suppl):81-4. PubMed ID: 12647425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired insight into delusions predicts treatment outcome during a randomized controlled trial for Psychotic Depression (STOP-PD study).
    Gerretsen P; Flint AJ; Whyte EM; Rothschild AJ; Meyers BS; Mulsant BH
    J Clin Psychiatry; 2015 Apr; 76(4):427-33. PubMed ID: 25919834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.